Chia-Ling Wu

2PUBLICATIONS
6CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 07, 2026
Oncogenic PIK3CA mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.

|Jul 13, 2024
TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab.

Bunpei Isoda, Shuya Kandori, Tomokazu Sazuka

Pageof 1

Frequent Collaborators

1 joint publications

Bunpei Isoda

1 joint publications

Shuya Kandori

1 joint publications

Hiroaki Sato

1 joint publications

Bryan J Mathis